TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 3 | 1 | 3 | 5 | 5 | -35 | -91 | -19 |
| P | %wins | 67 | 67 | 67 | 67 | 0 | 0 | 44 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/22/16 13:43 | 8/18/16 | EIGR | Eiger Biopharmaceuticals, Inc. | Health | BioPrd | Biological Products, (No Diag | Vivo Ventures Vi, LLC | CA | T | P | 3,000 | 16.00 | 1 | 188 | 12 | 1,787 | I | -91 | 0 | 15 | -21 | -18 | -23 | -11 | -9 | 5 | 1 | -10 | -19 | -29 | |||
4/24/15 19:03 | 4/14/15 | CBYL | Carbylan Therapeutics, Inc. | Health | Drug | Pharmaceutical Preparations | Vivo Ventures Vi, LLC | CA | T | P.ad | 5,063 | 5.00 | 2 | 1,013 | 32 | 4,205 | I | 42 | 3 | -8 | -32 | 1 | 0 | -53 | -88 | ||||||||
4/14/15 17:19 | 4/14/15 | CBYL | Carbylan Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Vivo Ventures Vi, LLC | CA | T | P.d | 5,063 | 5.00 | 3 | 1,013 | 32 | 4,205 | I | 5 | 40 | 24 | 35 | -24 | -94 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |